Design and Implementation of the Pediatric Liver Transplantation Biobank
Children's Hospital of Chongqing Medical University
1 other identifier
observational
500
1 country
1
Brief Summary
The purpose of the pediatric liver transplant biobank is to systematically collect clinical specimens from pediatric end-stage liver disease. It is expected to contribute to the research and development of paediatric end-stage liver disease in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 8, 2020
CompletedFirst Posted
Study publicly available on registry
July 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
ExpectedJuly 20, 2020
July 1, 2020
2.3 years
July 8, 2020
July 15, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Biological sample bank
A repository of biological samples from patients who will join the project, will be organised at the biobank center of the Children's Hospital of Chongqing Medical University(CHCMU) under the responsibility of the experienced staff at the Department of Hepatic.
2 years
Integrated health data platform
Collect patient clinical test information and establish diagnostic database.
2 years
Interventions
There are no interventions because it is a protocol study
Eligibility Criteria
Children with end-stage liver disease who undergo liver transplantation in our hospital. Obtain their or their parents' informed consent before the project starts.
You may qualify if:
- Children diagnosed with end-stage liver disease.
- Liver transplantation in our hospital.
- informed patient consent.
- long-term follow-up in our hospital.
You may not qualify if:
- No fixed contact information, difficult to follow up the patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400014, China
Related Publications (1)
Xiang Z, Wang R, Lu Y, Li Y, Wang H, Xiong Q, Dai X, Guo H, Deng Y, Le Y, Zhang M, Zhao Y. Study Protocol: Design and Implementation of the Pediatric Liver Transplantation Biobank. Biopreserv Biobank. 2021 Apr;19(2):111-118. doi: 10.1089/bio.2020.0128. Epub 2021 Apr 12.
PMID: 33847526DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dean
Study Record Dates
First Submitted
July 8, 2020
First Posted
July 20, 2020
Study Start
October 1, 2018
Primary Completion
January 1, 2021
Study Completion (Estimated)
July 1, 2028
Last Updated
July 20, 2020
Record last verified: 2020-07